NPS Intelligence (beta)

Disclosed NPS & retention by vertical

Verticals  /  Pharma, medtech & health distribution  /  Non-Big Three PBMs

Non-Big Three PBMs

4
Latest disclosed NPS
20 Oct 2026
1
NPS entries
1 with a number
2026
Years covered
1 entries in all

In their words

“Alternative PBM Net Promoter Score fell from +16 to +4, declining relative to Big Three PBMs; customer satisfaction metrics also declined.”
— reported by drugchannels.net · 20 Oct 2026 · NI-2B53A71

NPS disclosures (1)

Search the database →

20 Oct 2026
NPS4

Alternative PBM Net Promoter Score fell from +16 to +4, declining relative to Big Three PBMs; customer satisfaction metrics also declined.

— reported by drugchannels.net · 20 Oct 2026 · NI-2B53A71
drugchannels.net ↗

Retention disclosures (0)

Open in the retention database →

No retention figures yet.

Lighthouse companies in Pharma, medtech & health distribution

The whole vertical →

About these figures

Every figure here was publicly disclosed by the named company: press releases, annual reports, SEC filings, earnings calls and news coverage. Companies tend to publish their NPS when it is good, so these numbers run higher than a true industry average: read them as what leading companies in this vertical say publicly, not as an industry benchmark.

NPS runs from −100 to +100. Retention figures are reported as the company defines them (net revenue retention, gross revenue retention, customer retention rate, churn). Every entry links to its source in the full database.